- Home
- GFAI vs OVID Comparison
GFAI vs OVID Comparison
Compare GFAI & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GFAI
- OVID
- Stock Information
- Founded
- GFAI 2018
- OVID 2014
- Country
- GFAI Singapore
- OVID United States
- Employees
- GFAI N/A
- OVID N/A
- Industry
- GFAI Diversified Commercial Services
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- GFAI Consumer Discretionary
- OVID Health Care
- Exchange
- GFAI Nasdaq
- OVID Nasdaq
- Market Cap
- GFAI 20.7M
- OVID 24.0M
- IPO Year
- GFAI N/A
- OVID 2017
- Fundamental
- Price
- GFAI $1.07
- OVID $0.29
- Analyst Decision
- GFAI Strong Buy
- OVID Strong Buy
- Analyst Count
- GFAI 2
- OVID 6
- Target Price
- GFAI $6.75
- OVID $3.03
- AVG Volume (30 Days)
- GFAI 225.0K
- OVID 376.8K
- Earning Date
- GFAI 04-28-2025
- OVID 05-20-2025
- Dividend Yield
- GFAI N/A
- OVID N/A
- EPS Growth
- GFAI N/A
- OVID N/A
- EPS
- GFAI N/A
- OVID N/A
- Revenue
- GFAI $36,347,373.00
- OVID $566,000.00
- Revenue This Year
- GFAI $5.80
- OVID N/A
- Revenue Next Year
- GFAI $4.56
- OVID $36.11
- P/E Ratio
- GFAI N/A
- OVID N/A
- Revenue Growth
- GFAI 0.18
- OVID 44.39
- 52 Week Low
- GFAI $0.76
- OVID $0.24
- 52 Week High
- GFAI $3.88
- OVID $3.43
- Technical
- Relative Strength Index (RSI)
- GFAI 53.29
- OVID 39.90
- Support Level
- GFAI $0.99
- OVID $0.28
- Resistance Level
- GFAI $1.07
- OVID $0.33
- Average True Range (ATR)
- GFAI 0.07
- OVID 0.03
- MACD
- GFAI 0.01
- OVID 0.00
- Stochastic Oscillator
- GFAI 49.75
- OVID 16.97
About GFAI Guardforce AI Co. Limited
Guardforce AI Co Ltd is a provider of cash solutions and cash handling services located in Thailand. The company engages in the cash logistics business, and its services include cash-in-transit, or CIT, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions (cash deposit management and express cash service). Its customers include local commercial banks, chain retailers, coin-manufacturing mints, and government authorities.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.